Theralink Technologies

United States
Alameda, California, United States, 80401

Company profile

Theralink Technologies company profile

Theralink Technologies is a molecular company specializing in patented, biomarker assay services that target multiple areas of oncology. Their research indicates that genomic and transcriptomic information alone provides an incomplete information resource for physicians to make patient-specific treatment decisions. The company was founded in 2005 and is headquartered in Baton Rouge, Louisiana.

Business identity

Contact email
[email protected]
Phone number
888-585-4923
Operating status
Closed
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2005-01-01, Year

Headquarters

Postal code
80401
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
IPO
Funding rounds
4
Total equity funding
$4.2M
Last funding
Post IPO Equity / $3.1M / 2022-11-29
Last equity funding
Post IPO Equity / $3.1M
Articles
14
Closed on
2023-12-01
Exited on
2010-04-01

Founders and investors

No public relation records are available.